| Natera, Inc. Common Stock | $38.9b | $271.38 | +0.6% | 839.2K | |
| Guardant Health, Inc. Common Stock | $19.9b | $153.25 | +0.6% | 1.7M | |
| BillionToOne, Inc. Class A Common Stock | $5.5b | $129.50 | +1.6% | 595.7K | |
| Caris Life Sciences, Inc. Common Stock | $5.0b | $16.73 | +0.0% | 2.8M | |
| Veracyte, Inc. | $4.7b | $58.91 | -0.1% | 932.9K | |
| Adaptive Biotechnologies Corporation Common Stock | $3.4b | $22.84 | +3.7% | 2.8M | |
| GRAIL, Inc. Common Stock | $2.9b | $71.52 | +0.8% | 322.1K | |
| NeoGenomics, Inc. | $1.9b | $14.63 | -1.6% | 6.7M | |
| Personalis, Inc. Common Stock | $1.4b | $15.47 | -1.2% | 6.2M | |
| Castle Biosciences, Inc. Common Stock | $0.7b | $24.11 | -0.4% | 198.3K | |
| Fulgent Genetics, Inc. Common Stock | $0.6b | $20.16 | -1.9% | 125.0K | |
| The Oncology Institute, Inc. Common Stock | $0.5b | $5.33 | +1.8% | 1.3M | |
| Myriad Genetics Inc | $0.5b | $6.18 | -0.2% | 625.2K | |
| AngioDynamics, Inc. | $0.5b | $13.48 | -4.6% | 440.4K | |
| Biodesix, Inc. Common Stock | $233.5m | $20.65 | +0.2% | 37.6K | |
| Lucid Diagnostics Inc. Common Stock | $204.1m | $0.97 | -6.3% | 2.9M | |
| Sensus Healthcare, Inc | $49.7m | $3.00 | -1.5% | 17.7K | |
| Precipio, Inc. Common Stock | $44.3m | $24.48 | +0.9% | 107.7K | |
| PAVmed Inc. Common Stock | $42.5m | $6.03 | 0.0% | 6.9K | |
| Quantum Cyber N.V. Ordinary Shares | $35.7m | $1.21 | +2.5% | 708.8K | |
| MDxHealth SA Ordinary Shares | $21.1m | $0.42 | -0.6% | 309.3K | |
| VolitionRx Limited | $16.1m | $1.10 | -5.2% | 98.5K | |
| Advanced Biomed Inc. Common Stock | $7.7m | $6.38 | +5.9% | 10.2K | |
| 20/20 Biolabs, Inc. Common Stock | $6.7m | $0.52 | 0.0% | 75.3K | |
| bioAffinity Technologies, Inc. Common Stock | $5.1m | $0.71 | -1.5% | 57.3K | |
| Onconetix, Inc. Common Stock | $4.2m | $0.76 | -3.1% | 73.4K | |
| Avalon GloboCare Corp. Common Stock | $3.5m | $0.30 | -4.4% | 1.1M | |
| Zhongchao Inc. Class A Ordinary Shares | $1.2m | $1.58 | -2.9% | 41.9K |